ORLANDO, Florida — Use of cannabis is common in patients with multiple sclerosis (MS), especially for the treatment of MS-related spasticity, new research suggests. Findings from a survey conducted ...

(HealthDay News) – Smoking cannabis is associated with a reduction in spasticity for patients with multiple sclerosis (MS), according to a study published online May 14 in CMAJ, the journal of the ...

December 10, 2009 — Cannabis may be a viable treatment option for some patients with spasticity related to multiple sclerosis (MS), new research suggests. The systematic review, conducted by ...

A new study found smoking cannabis reduced spasticity in MS patients. May 14, 2012— -- Smoking marijuana may reduce certain symptoms in patients with multiple sclerosis, according to a new small ...

Dec. 5 -- FRIDAY, Dec. 4 (HealthDay News) -- Cancer patients, glaucoma patients and others can benefit from medical marijuana, and now a new analysis shows that it can help multiple sclerosis (MS) ...

The study, published Monday, found that for 30 MS patients with muscle "spasticity," a few days of marijuana smoking brought some relief. But the big caveat, researchers say, is that it's not clear ...

In the US alone, over 400,000 Americans struggle with to manage the daily symptoms of Multiple Sclerosis (MS). MS is an autoimmune disorder that presents with neurologic manifestations. Patients may ...

DUBLIN, June 28, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase 3 RELEASE MSS1 trial (NCT04657666) evaluating nabiximols oromucosal spray ...

Arbaclofen extended-release (ER) reduced spasticity in patients with multiple sclerosis and was found to be safe and well-tolerated, according to 2 new abstracts presented at the 33rd Annual Meeting ...

Investigators sought to determine the safety and efficacy of twice-daily dosing of arbaclofen ER in patients with spasticity due to multiple sclerosis. SEATTLE – Twice-daily arbaclofen ...